Bone morphogenetic proteins and cancer: review of the literature. - Wikidata - wikimedia - TriplyDB

Bone morphogenetic proteins and cancer: review of the literature.

Bone morphogenetic proteins and cancer: review of the literature.

http://www.wikidata.org/entity/Q37665275

about

Germline mutations in SMAD4 disrupt bone morphogenetic protein signaling BMPs and their clinical potentials BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer BMP-specific SMADs function as novel repressors of PDGFA and modulate its expression in ovarian granulosa cells and tumors.Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2)Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration.Intradiscal injection of simvastatin results in radiologic, histologic, and genetic evidence of disc regeneration in a rat model of degenerative disc disease BMP2 promotes proliferation and invasion of nasopharyngeal carcinoma cells via mTORC1 pathway Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study.Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes Cancer risk from bone morphogenetic protein exposure in spinal arthrodesis.Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma.BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.Construction of a eukaryotic expression vector pEGFP-C1-BMP-2 and its effect on cell migration.Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy.Bone regeneration in strong porous bioactive glass (13-93) scaffolds with an oriented microstructure implanted in rat calvarial defects Autosomal dominant mesomandibular fibro-osseous dysplasia: a self-resolving inherited fibro-osseous lesion of the jaws The use of rhBMP in spine surgery: is there a cancer risk?VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma.Platelet-Rich Plasma-Loaded Poly(d,l-lactide)-Poly(ethylene glycol)-Poly(d,l-lactide) Hydrogel Dressing Promotes Full-Thickness Skin Wound Healing in a Rodent Model rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo.Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis.BMP signaling and its paradoxical effects in tumorigenesis and dissemination.Spinal reconstruction with pedicle screw-based instrumentation and rhBMP-2 in patients with neurofibromatosis and severe dural ectasia and spinal deformity: report of two cases and a review of the literature.Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine.Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?The role of stem cell therapies in degenerative lumbar spine disease: a review.SP1 regulates the transcription of BMPR1A.Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.BMP4/Thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumors.B2A, a receptor modulator, increases the growth of pluripotent and preosteoblast cells through bone morphogenetic protein receptors.Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.

P2860

Q24304900-686EE91D-C200-43C9-A46C-43EC5B30552E Q26824827-196D8DE1-0828-49BC-8435-C4BAD31C8322 Q28296361-A50F96E2-901A-4ED7-AF91-B39910502D66 Q28511586-E6198988-DE54-4DB8-BC98-FE930C4E949C Q31813073-811C78F3-18A1-4687-A951-BBD318993883 Q33553896-2B6ED569-F73D-4621-8A97-610EB3A39EFB Q33639409-85CD1358-F6D1-4C4E-8647-658373CAA0C2 Q33656393-EEDA8BAC-9860-44AF-8AEA-51D7925A713C Q33657520-5255F984-3283-4591-83BA-4695F48B86A7 Q33799599-4F71D561-A010-4A6D-9D56-68C29F085E32 Q33804283-79B6E239-2D00-4776-B2C5-76E285CEA7FE Q34084057-B2780F25-00A7-4CEB-8A7C-2442A172E991 Q34087981-637FC204-72D6-4C9D-A2EF-ED3883F07270 Q34437606-D67A9923-6A09-42E7-85B5-769B42B8323D Q35075436-4599FC78-0DE0-4719-8B68-FB9B4EE6D560 Q35532091-DF2543D7-8F14-48BD-8F03-98BB1BA51BB0 Q35591577-321602ED-06F9-4DE7-8EC6-BC3FA4BB1285 Q35946399-461F699D-C5CD-41B6-B4E9-B666D4A1CE70 Q36035290-240D5D72-73B3-4549-85D8-82DD99E8C867 Q36069376-C0FEEA00-C82E-48EF-8FFD-17CEDA04718C Q36238087-EE30340F-793F-4AB6-9BAD-FDEED3F52E14 Q36428986-0B4BCD15-5FF1-4CC4-BEBE-FA577A3D93A8 Q36449176-CD3720E0-CBFB-4EF7-A0EF-E598CD7C4E1B Q36451255-851E54E8-54B5-4046-BA2A-6FDBEF7B613B Q36518633-96F98722-0BA0-4523-93C7-87E21EE427EC Q36629525-27E32C78-2595-46DA-BCE2-271CAD3AAD70 Q37134322-113323E7-389F-422C-8246-F24AB591C367 Q37492007-1D2B059E-2A6D-49DB-907E-95B44A146FAA Q37706935-9E3C6A9C-EFB2-48FC-BA38-B7FFF10E38B3 Q37718513-D08805C3-F544-40F4-BE15-00EF711D4FAC Q37931671-7119F575-C9CE-4F50-A0E5-6598859D1339 Q38112605-05223D3F-1B75-4CB2-8AA3-D85418B60700 Q38115632-06AFE305-ADBC-439B-8B9B-2A0B7BC6725C Q38370139-5F34C715-DAF7-452F-B9F3-FC20A590F36F Q38738588-8F004D24-1150-4450-BA20-2B1D25027B58 Q38904950-4C58FB23-9B54-425E-A489-C4B0566994A0 Q39098777-EAA2E5A9-8617-4BF9-9671-73EA2CCA1F67 Q39227934-F47E4D90-CE82-4CD7-A3DC-9A1D20C84037 Q39370416-8C0CC322-2165-4336-8174-5B8ACA0F96F4 Q39390484-CD7CE99F-3F7C-4B02-8EC1-9F2293F754DF

P2860

Bone morphogenetic proteins and cancer: review of the literature.

http://www.wikidata.org/entity/Q37665275

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bone morphogenetic proteins and cancer: review of the literature.

@en

Bone morphogenetic proteins and cancer: review of the literature.

@nl

type

label

Bone morphogenetic proteins and cancer: review of the literature.

@en

Bone morphogenetic proteins and cancer: review of the literature.

@nl

prefLabel

Bone morphogenetic proteins and cancer: review of the literature.

@en

Bone morphogenetic proteins and cancer: review of the literature.

@nl

P1433

Q37665275-8D92814B-5200-43AC-9E10-795F22358AE0

P1476

Q37665275-0341C079-FBB4-4C26-95D4-7B1D025B283C

P2093

Q37665275-8FB6E694-CF93-40A4-B6F9-F5F29587FAAE

Q37665275-A3BB9DA7-5525-4C4E-A1E0-1D70A506921F

Q37665275-ABBC81FC-7DC3-4D42-81F1-27D1C7E35517

Q37665275-ABF85A7F-8344-47AA-91FC-A331EA72F9D8

Q37665275-C9CF6429-2352-4A6F-9119-2596F283F5F9

Q37665275-E03C7473-5062-4180-9224-6DFDA5B597C9

P2860

Q37665275-0894AFAE-4344-4352-9D3B-96D0B0606BCD

Q37665275-09C4C843-AE4D-40B7-82FB-2E08BFCF03B7

Q37665275-11C2B9F8-22C7-4BD6-86C8-5F0914F6CB6A

Q37665275-1830DE42-88CD-441C-8F87-9A7758B7B1D8

Q37665275-18FF3A8F-6D1F-4E12-A71A-8E34ECE83F6F

Q37665275-1AA189AB-B44E-4C7D-99B5-C558BFFB8F49

Q37665275-243CC9BC-069D-4638-AD18-A0E2994E63FC

Q37665275-26A49968-A0D2-435A-9B1E-CCBE75A604E3

Q37665275-31103F2C-487E-4E8B-A460-158783450C17

Q37665275-32E1D0C1-02C4-4825-956B-9F4A36E8D41F

P304

Q37665275-C77D39AF-B65F-4099-8A67-ABC87F3088C9

P31

Q37665275-51EA9575-AB34-4BDE-8A9A-AA472FA35931

P356

Q37665275-7687708E-07B1-42BE-950B-F29CB86138AC

P407

Q37665275-057E2B22-75CA-4383-937A-4EA41FB2A9A6

P433

Q37665275-AB3BA870-A582-4412-982B-695D11CDEA90

P478

Q37665275-CEABDAE1-E136-49DC-8F31-5FF2289FB2FA

P577

Q37665275-AA82DCB8-0BCF-4A40-83AA-AE594CBA16E7

P5875

Q37665275-C4DBB234-2CFD-4A4A-994D-BAD5E1BB3FAE

P698

Q37665275-3A3D003C-A5CD-4000-85FE-9FBDA4698CAB

P921

Q37665275-6D5420CA-CE9B-4D8E-A0F8-0F6C04EECA63

P356

01.NEU.0000363722.42097.C2

P1433

P1476

Bone morphogenetic proteins and cancer: review of the literature.

@en

P2093

Anthony C Wang

http://www.w3.org/2001/XMLSchema#string

Chia-Ying Lin

http://www.w3.org/2001/XMLSchema#string

Frank La Marca

http://www.w3.org/2001/XMLSchema#string

Jayesh P Thawani

http://www.w3.org/2001/XMLSchema#string

Khoi D Than

http://www.w3.org/2001/XMLSchema#string

Paul Park

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human bone morphogenetic protein induces bone formation

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells

Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo

Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family

Cloning and characterization of a human type II receptor for bone morphogenetic proteins

Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

The consensus coding sequences of human breast and colorectal cancers

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

Collagen sponges for bone regeneration with rhBMP-2

P304

233-46; discussion 246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1227/01.NEU.0000363722.42097.C2

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40819940

http://www.w3.org/2001/XMLSchema#string

P698

20042986

http://www.w3.org/2001/XMLSchema#string

P921